IMPORTANCE OF DIVERSE POPULATIONS IN CLINICAL TRIALS Clinical trials are a vital stage in the development of any drug for market. However, they can have weaknesses, and a common one is the demographic makeup of the trial population. In some cases, a narrow patient group is needed, but in others, especially vaccine trials, you need...

Q&A WITH DR. EDDILISA MARTIN: WHY REPRESENTATION MATTERS IN CLINICAL TRIALS After researchers examined demographic characteristics of 230 US-based clinical trials from July 2011 through June 2020, they found startling results. Among the 219,555 clinical trial participants, White individuals were overrepresented 78 percent of the time, Hispanic participants were represented just 12 percent of the...

WHAT IS DIVERSITY IN CLINICAL TRIALS? Clinical trials play an essential role in achieving positive health outcomes for patients of every race, gender, sex, age, geography and socioeconomic status. With that realization, a growing number of biopharmaceutical companies are seeking to conduct more diverse and representative trials that ensure treatments address real-world patient needs.  But...

Q&A WITH OUR LEADERSHIP TEAM: WHY 2M CLINICAL AND WHY NOW? 2M Clinical’s roots began when Dr. Eddilisa Martin and Dr. Marcus Martin founded 2M Research in 2011. Since then, the company has grown to include a broad and diverse client portfolio across many different federal, state, academic, and non-profit entities, with locations in Texas...